Cue Biopharma (CUE) Short-Term Debt repayments (2023 - 2025)
Historic Short-Term Debt repayments for Cue Biopharma (CUE) over the last 3 years, with Q3 2025 value amounting to -$1.0 million.
- Cue Biopharma's Short-Term Debt repayments changed 0.0% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 million, marking a year-over-year increase of 2.5%. This contributed to the annual value of -$4.0 million for FY2024, which is 9995.0% down from last year.
- As of Q3 2025, Cue Biopharma's Short-Term Debt repayments stood at -$1.0 million, which was down 0.0% from -$1.0 million recorded in Q2 2025.
- In the past 5 years, Cue Biopharma's Short-Term Debt repayments registered a high of -$999000.0 during Q4 2024, and its lowest value of -$1.0 million during Q3 2023.
- For the 3-year period, Cue Biopharma's Short-Term Debt repayments averaged around -$999888.9, with its median value being -$1.0 million (2023).
- Examining YoY changes over the last 5 years, Cue Biopharma's Short-Term Debt repayments showed a top increase of 10.0% in 2024 and a maximum decrease of 0.0% in 2024.
- Over the past 3 years, Cue Biopharma's Short-Term Debt repayments (Quarter) stood at -$1.0 million in 2023, then grew by 0.1% to -$999000.0 in 2024, then decreased by 0.1% to -$1.0 million in 2025.
- Its Short-Term Debt repayments was -$1.0 million in Q3 2025, compared to -$1.0 million in Q2 2025 and -$1.0 million in Q1 2025.